New Horizons – SDH-deficient GIST Research Update
Dr. Shruti Bhargava, University of California San Diego, presented SDH-deficient GIST Research Updates at New Horizons 2021.
New Horizons – Long-term GIST Survivor Story
Chuck Korte presented his story as Long-term GIST Survivor at New Horizons 2021.
Clinical Trials Update – December 2021
December 2021 - In this summary, we have highlighted recent clinical trials that are still recruiting in the U.S. which investigate potential treatments for GIST patients.
The LRG 2021 Holiday Wish List
As we enter the holiday season, and our thoughts turn to the new year to come, we made a list of our holiday wishes. - That no patient dies because they didn’t receive the [...]
Immunotherapy and GIST
This webinar provided an overview of immunotherapy with some examples of studies exploring single agent versus combination of therapy in GIST.
Patient of the Month for November: Americo Blancato
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Americo Blancato shares his story.
Breaking News: Additional Commentary for “It’s Time to Rethink Placebos in Advanced GIST” – LRG Science
In this issue of LRG Science, we present additional commentary on our Sept. issue: "It's Time to Rethink Placebos in Advanced GIST".
Caring for the Caregiver
Caring for the Caregiver focused on common challenges caregivers experience and how these challenges can often lead to burnout, while also highlighting the impact of COVID-19.
Perspectives in Biomarker Testing
This video is about understanding the role of mutations and biomarker testing in GIST. Knowing the driving force behind each individual’s tumors is not just important, it is critical in determining the most effective treatment for your mutation.
Tissue Testing Project
The Life Raft Group (LRG) is providing you with this information to let you know that comprehensive genomic profiling, also known as biomarker testing or molecular testing, is a crucial step in understanding the genomic factors that play a role in a GIST diagnosis. Bayer Pharmaceuticals, in partnership with The Life Raft Group (LRG), has extended a research collaboration to broaden access to comprehensive genomic testing (CGT) for Gastrointestinal Stromal Tumor (GIST) patients.